LEADER 04485nam 22006854a 450 001 9910961128603321 005 20200520144314.0 010 $a9786610953301 010 $a9781280953309 010 $a1280953306 010 $a9789291736027 010 $a9291736023 035 $a(CKB)1000000000688388 035 $a(EBL)305224 035 $a(OCoLC)476082608 035 $a(SSID)ssj0000280249 035 $a(PQKBManifestationID)11224750 035 $a(PQKBTitleCode)TC0000280249 035 $a(PQKBWorkID)10290480 035 $a(PQKB)11138159 035 $a(MiAaPQ)EBC305224 035 $a(Au-PeEL)EBL305224 035 $a(CaPaEBR)ebr10190614 035 $a(CaONFJC)MIL95330 035 $a(NjHacI)991000000000688388 035 $a(Perlego)1840043 035 $a(EXLCZ)991000000000688388 100 $a20061204d2006 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aHigh coverage sites $eHIV prevention among injecting drug users in transitional and developing countries : case studies 205 $a1st ed. 210 $aGeneva $cUNAIDS$d2006 215 $a1 online resource (80 p.) 225 1 $aUNAIDS best practice collection 300 $aDescription based upon print version of record. 311 08$a9789291735310 311 08$a9291735310 320 $aIncludes bibliographical references. 327 $aCONTENTS; Tables; Abbreviations and Terms; Executive Summary; 1. Introduction and Methods; Definitions; 2. Case Studies: Eastern Europe; 2.1 Soligorsk, Belarus; 2.1.1 Summary; 2.1.2 Drug use and HIV situation; 2.1.3 History; 2.1.4 Features of services; 2.1.5 Coverage; 2.1.6 Maintaining and expanding coverage; 2.1.7 Further reading; 2.2 Pskov, Russian Federation; 2.2.1 Summary; 2.2.2 Drug use and HIV situation; 2.2.3 History; 2.2.4 Features of services; 2.2.5 Coverage; 2.2.6 Maintaining and expanding coverage; 2.2.7 Further reading; 2.3 Sumy, Ukraine; 2.3.1 Summary 327 $a2.3.2 Drug use and HIV situation2.3.3 History; 2.3.4 Features of services; 2.3.5 Coverage; 2.3.6 Maintaining and expanding coverage; 2.3.7 Further reading; 3. Case Studies: Asia; 3.1 Dhaka, People's Republic of Bangladesh; 3.1.1 Summary; 3.1.2 Drug use and HIV situation; 3.1.3 History; 3.1.4 Features of services; 3.1.5 Coverage; 3.1.6 Maintaining and expanding coverage; 3.1.7 Further reading; 3.2 Rajshahi, People's Republic of Bangladesh; 3.2.1 Summary; 3.2.2 Drug use and HIV situation; 3.2.3 History; 3.2.4 Features of services; 3.2.5 Coverage; 3.2.6 Maintaining and expanding coverage 327 $a3.2.7 Further reading3.3 Hong Kong Special Administrative Region (Hong Kong SAR), People's Republic of China; 3.3.1 Summary; 3.3.2 Drug use and HIV situation; 3.3.3 History; 3.3.4 Features of services; 3.3.5 Coverage; 3.3.6 Maintaining and expanding coverage; 3.3.7 Further reading; 4. Case Studies: Latin America; 4.1 Salvador, Brazil; 4.1.1 Summary; 4.1.2 Drug use and HIV situation; 4.1.3 History; 4.1.4 Features of services; 4.1.5 Coverage; 4.1.6 Maintaining and expanding coverage; 4.1.7 Further reading; 5. Lessons learnt: High-coverage sites; 5.1 Common features of high-coverage programmes 327 $a5.2 Challenges for comprehensive HIV-related programmes5.3 Minimal coverage monitoring and estimation; 5.4 Recommendations for further research 330 $aUNAIDS commissioned this report to investigate programmes and sites in low-income and transitional countries which were regarded by international authorities as 'high coverage sites' -that is, where more than 50% of injecting drug users had been reached by one or more HIV-prevention interventions. The most significant finding is that high level coverage can be attained by interventions addressing HIV among injecting drug users in developing and transitional countries. The seven case studies each include a description of the development of the programme and features of the services provided, an 410 0$aUNAIDS best practice collection. 606 $aAIDS (Disease)$zDeveloping countries$xPrevention$vCase studies 606 $aIntravenous drug abusers$zDeveloping countries 615 0$aAIDS (Disease)$xPrevention 615 0$aIntravenous drug abusers 676 $a362.196/97920091724 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910961128603321 996 $aHigh coverage sites$94367254 997 $aUNINA LEADER 02680oas 2201153 a 450 001 9910140850003321 005 20251106213014.0 011 $a1934-9440 035 $a(DE-599)ZDB2379216-4 035 $a(OCoLC)60623113 035 $a(CONSER) 2006215113 035 $a(CKB)110978966554136 035 $a(EXLCZ)99110978966554136 100 $a20050614a19749999 sy a 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aCytology and genetics 210 $a[New York] $cAllerton Press 210 2$aJersey City, NJ :$cSpringer Nature 215 $a1 online resource 300 $aRefereed/Peer-reviewed 311 08$a0095-4527 606 $aGenetics$vPeriodicals 606 $aCytology$vPeriodicals 606 $aCytogenetics 606 $aCytologie$vPe?riodiques 606 $aGe?ne?tique$vPe?riodiques 606 $aCytoge?ne?tique 606 $aCytology$2fast$3(OCoLC)fst00886282 606 $aGenetics$2fast$3(OCoLC)fst00940117 606 $aCitogenètica$2thub 606 $aGenètica$2thub 606 $aCitologia$2thub 608 $aperiodicals.$2aat 608 $aPeriodicals.$2fast 608 $aPeriodicals.$2lcgft 608 $aPe?riodiques.$2rvmgf 608 $aRevistes electròniques.$2thub 615 0$aGenetics 615 0$aCytology 615 2$aCytogenetics. 615 6$aCytologie 615 6$aGe?ne?tique 615 6$aCytoge?ne?tique. 615 7$aCytology. 615 7$aGenetics. 615 7$aCitogenètica. 615 7$aGenètica. 615 7$aCitologia. 676 $a574.8/7/05 801 0$bOCLCS 801 1$bOCLCS 801 2$bNSD 801 2$bOCLCQ 801 2$bCUS 801 2$bOCLCQ 801 2$bOCLCF 801 2$bOCLCO 801 2$bOCLCQ 801 2$bOCLCO 801 2$bOCLCQ 801 2$bSCB 801 2$bOCLCO 801 2$bOCLCA 801 2$bZ5A 801 2$bOCLCO 801 2$bOCLCA 801 2$bREB 801 2$bOCLCO 801 2$bAU@ 801 2$bOCLCO 801 2$bWYU 801 2$bOCLCO 801 2$bUKMGB 801 2$bAUD 801 2$bVT2 801 2$bU3W 801 2$bCNTRU 801 2$bNJT 801 2$bOCLCO 801 2$bDLC 801 2$bCASUM 801 2$bOCLCA 801 2$bUBY 801 2$bDLC 801 2$bOCLCQ 801 2$bUAB 801 2$bSFB 801 2$bLIP 801 2$bADU 801 2$bS2H 801 2$bOCLCQ 906 $aJOURNAL 912 $a9910140850003321 996 $aCytology and genetics$92292500 997 $aUNINA